20% of participants had 80% reduction in AHI. the average was 44% reduction in AHI across the spectrum. Pre meeting arranged with FDA.
- Forums
- ASX - By Stock
- IHL
- Ann: IHL-42X positive phase 2 clinical trial results
Ann: IHL-42X positive phase 2 clinical trial results, page-21
-
-
- There are more pages in this discussion • 369 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)